2008
DOI: 10.1128/iai.00005-08
|View full text |Cite
|
Sign up to set email alerts
|

Differential Activation of Human and Mouse Toll-Like Receptor 4 by the Adjuvant Candidate LpxL1 ofNeisseria meningitidis

Abstract: Neisseria meningitidis LpxL1 lipopolysaccharide (LPS) bearing penta-acylated lipid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
48
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 72 publications
(54 citation statements)
references
References 39 publications
5
48
0
1
Order By: Relevance
“…We have described previously that the pentaacylated LPS from an lpxL1 Ϫ mutant of N. meningitidis, lacking the secondary C12:0 acyl chain at the 2Ј-position of lipid A, has reduced endotoxicity but similar adjuvant activity in mice as compared with wild-type meningococcal LPS (14,39). However, the lpxL1 Ϫ LPS was more strongly reduced in its ability to activate human as compared with murine TLR4, as measured by the expression of the NF-B transcription factor and various MyD88-dependent cytokines (40). For PagL-deacylated meningococcal LPS, adjuvant activity has also been demonstrated in mice, but it should be noted that in this animal species there is very little difference in endotoxic activity compared with wild-type hexaacylated LPS (41).…”
Section: Discussionmentioning
confidence: 92%
“…We have described previously that the pentaacylated LPS from an lpxL1 Ϫ mutant of N. meningitidis, lacking the secondary C12:0 acyl chain at the 2Ј-position of lipid A, has reduced endotoxicity but similar adjuvant activity in mice as compared with wild-type meningococcal LPS (14,39). However, the lpxL1 Ϫ LPS was more strongly reduced in its ability to activate human as compared with murine TLR4, as measured by the expression of the NF-B transcription factor and various MyD88-dependent cytokines (40). For PagL-deacylated meningococcal LPS, adjuvant activity has also been demonstrated in mice, but it should be noted that in this animal species there is very little difference in endotoxic activity compared with wild-type hexaacylated LPS (41).…”
Section: Discussionmentioning
confidence: 92%
“…The extracellular domains of mouse and human TLR4 show only 62% sequence similarity, while the hypervariable ligand binding regions have only 48% sequence similarity (9,47). Moreover, species differences for MD-2, the coreceptor for TLR4, also affect the ligand recognition (48,49) and the structural basis for these species differences has been resolved (50), which highlights the differences in PAMP recognition between mouse TLR4 and human TLR4 (51)(52)(53)(54). Added to this are the TLR4 cellular expression patterns and tissue distributions.…”
Section: Discussionmentioning
confidence: 98%
“…6). N. meningitidis LpxL1 LPS, which specifically activates the murine but not human TLR4/ MD2 complex (47), also activated the chTLR4/chMD-2 complex, although the maximum response was reduced compared with the LPS of the parent strain (Fig. 6).…”
Section: Lps Specificity Of the Chtlr4/chmd-2 Complexmentioning
confidence: 98%